New Engineered-Botulinum Toxins Inhibit the Release of Pain-Related Mediators.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- New Engineered-Botulinum Toxins Inhibit the Release of Pain-Related Mediators.
- Published In:
- International journal of molecular sciences, 21(1) (2019)
- Authors:
- Tang, Minhong, Meng, Jianghui, Wang, Jiafu
- Database ID:
- RPEP-04505
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04505APA
Tang, Minhong; Meng, Jianghui; Wang, Jiafu. (2019). New Engineered-Botulinum Toxins Inhibit the Release of Pain-Related Mediators.. International journal of molecular sciences, 21(1). https://doi.org/10.3390/ijms21010262
MLA
Tang, Minhong, et al. "New Engineered-Botulinum Toxins Inhibit the Release of Pain-Related Mediators.." International journal of molecular sciences, 2019. https://doi.org/10.3390/ijms21010262
RethinkPeptides
RethinkPeptides Research Database. "New Engineered-Botulinum Toxins Inhibit the Release of Pain-..." RPEP-04505. Retrieved from https://rethinkpeptides.com/research/tang-2019-new-engineeredbotulinum-toxins-inhibit
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.